These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 17064698

  • 1. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy.
    Nakashima H, Inui T, Habu Y, Kinoshita M, Nagao S, Kawaguchi A, Miura S, Shinomiya N, Yagita H, Seki S.
    Gastroenterology; 2006 Nov; 131(5):1573-83. PubMed ID: 17064698
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 3. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice.
    Inui T, Nakashima H, Habu Y, Nakagawa R, Fukasawa M, Kinoshita M, Shinomiya N, Seki S.
    J Hepatol; 2005 Oct; 43(4):670-8. PubMed ID: 15922476
    [Abstract] [Full Text] [Related]

  • 4. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation.
    Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, Hatakeyama K, Abo T.
    Hepatology; 2000 Apr; 31(4):907-15. PubMed ID: 10733547
    [Abstract] [Full Text] [Related]

  • 5. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo.
    Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, Saito K, Takemura M, Sekikawa K, Imawari M, Seishima M, Moriwaki H.
    Hepatology; 2003 Nov; 38(5):1116-24. PubMed ID: 14578850
    [Abstract] [Full Text] [Related]

  • 6. In vivo activation of invariant V alpha 14 natural killer T cells by alpha-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity.
    Lisbonne M, Hachem P, Tonanny MB, Fourneau JM, Sidobre S, Kronenberg M, Van Endert P, Dy M, Schneider E, Leite-de-Moraes MC.
    Eur J Immunol; 2004 May; 34(5):1381-8. PubMed ID: 15114671
    [Abstract] [Full Text] [Related]

  • 7. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T, Tomita Y, Okano S, Iwai T, Yasunami Y, Yoshikai Y, Nomoto K, Yasui H, Tominaga R.
    Transplantation; 2007 Jan 27; 83(2):184-92. PubMed ID: 17264815
    [Abstract] [Full Text] [Related]

  • 8. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Yamamoto M, Fujita Y, Miyagi T, Ohkawa K, Hayashi N.
    J Hepatol; 2008 Nov 27; 49(5):779-86. PubMed ID: 18760855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
    Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, Kuranaga N, Fukasawa M, Shinomiya N, Seki S.
    J Immunol; 2002 Dec 01; 169(11):6127-32. PubMed ID: 12444115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z, Dhupar R, Cai C, Li P, Billiar TR, Geller DA.
    J Immunol; 2010 Aug 15; 185(4):2536-43. PubMed ID: 20624945
    [Abstract] [Full Text] [Related]

  • 17. Fas engagement accelerates liver regeneration after partial hepatectomy.
    Desbarats J, Newell MK.
    Nat Med; 2000 Aug 15; 6(8):920-3. PubMed ID: 10932231
    [Abstract] [Full Text] [Related]

  • 18. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S.
    J Immunol; 2001 Jun 01; 166(11):6578-84. PubMed ID: 11359810
    [Abstract] [Full Text] [Related]

  • 20. Effects of ischemic preconditioning on regenerative capacity of hepatocyte in the ischemically damaged rat livers.
    Bedirli A, Kerem M, Pasaoglu H, Erdem O, Ofluoglu E, Sakrak O.
    J Surg Res; 2005 May 01; 125(1):42-8. PubMed ID: 15836849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.